N-Nitroso-Pramipexole
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Pramipexole is used to treat Parkinson disease. It may be used alone or in combination with other medicines (eg, levodopa). Pramipexole is a dopamine agonist that works on the nervous system to help treat the symptoms of Parkinson disease. Pramipexole is also used to treat Restless Legs Syndrome (RLS). N-Nitroso-Pramipexole is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso-Pramipexole chemically represented as (S)-N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-propylnitrous amide .Synchemia is the leading manufacturing and exporter of N-Nitroso-Pramipexole . We supply N-Nitroso-Pramipexole with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014631 |
| CAS No | NA |
| Mol.F. | C22H17N7O |
| Mol.Wt. | 395.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014632 |
| CAS No | NA |
| Mol.F. | C22H17N7O |
| Mol.Wt. | 395.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014633 |
| CAS No | NA |
| Mol.F. | C22H16N8O2 |
| Mol.Wt. | 424.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014634 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 : Ca |
| Mol.Wt. | 486.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014635 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 : Ca |
| Mol.Wt. | 486.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014636 |
| CAS No | NA |
| Mol.F. | C20H21N9O8 : Ca |
| Mol.Wt. | 515.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014637 |
| CAS No | NA |
| Mol.F. | C20H20N6O7 |
| Mol.Wt. | 456.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014638 |
| CAS No | NA |
| Mol.F. | C20H19N7O8 |
| Mol.Wt. | 485.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014639 |
| CAS No | NA |
| Mol.F. | C20H20N6O7 |
| Mol.Wt. | 456.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014640 |
| CAS No | NA |
| Mol.F. | C19H19F3N4O4 |
| Mol.Wt. | 424.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014641 |
| CAS No | NA |
| Mol.F. | C16H17N5OS |
| Mol.Wt. | 327.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014642 |
| CAS No | NA |
| Mol.F. | C9H12N2O3 |
| Mol.Wt. | 196.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014643 |
| CAS No | NA |
| Mol.F. | C13H13N3O2 |
| Mol.Wt. | 243.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014644 |
| CAS No | NA |
| Mol.F. | C17H18N4O2 |
| Mol.Wt. | 310.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014645 |
| CAS No | NA |
| Mol.F. | C29H29N7O7 |
| Mol.Wt. | 587.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014646 |
| CAS No | NA |
| Mol.F. | C11H16N2O4 |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |